Yang, T., Shen, X., Tang, X., Wei, G., Zhang, H., Du, C., . . . Bi, J. (2011). Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer. Tumori, 97(4), 466-472. https://doi.org/10.1177/030089161109700409
Chicago Style (17th ed.) CitationYang, Tingsong, et al. "Phase II Trial of Oxaliplatin Plus Oral Capecitabine as First-line Chemotherapy for Patients with Advanced Gastric Cancer." Tumori 97, no. 4 (2011): 466-472. https://doi.org/10.1177/030089161109700409.
MLA (9th ed.) CitationYang, Tingsong, et al. "Phase II Trial of Oxaliplatin Plus Oral Capecitabine as First-line Chemotherapy for Patients with Advanced Gastric Cancer." Tumori, vol. 97, no. 4, 2011, pp. 466-472, https://doi.org/10.1177/030089161109700409.